HomeMarket NewsCDMO Stock Earnings: Avid Bioservices Misses EPS, Beats Revenue for Q3 2024

CDMO Stock Earnings: Avid Bioservices Misses EPS, Beats Revenue for Q3 2024

By Ron Finklestien
Current Market Analysis

Actionable Trade Ideas

always free

CDMO stock - CDMO Stock Earnings: Avid Bioservices Misses EPS, Beats Revenue for Q3 2024

Source: iQoncept / Shutterstock

Avid Bioservices (NASDAQ:CDMO) just reported results for the third quarter of 2024.

  • Avid Bioservices reported earnings per share of -8 cents. This was below the analyst estimate for EPS of -5 cents.
  • The company reported revenue of $33.82 million.
  • This was 1.09% better than the analyst estimate for revenue of $33.45 million.

InvestorPlace Earnings is a project that leverages data from TradeSmith to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at [email protected].

Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/04/cdmo-stock-earnings-avid-bioservices-for-q3-of-2024/.

©2024 InvestorPlace Media, LLC

Swing Trading Ideas and Market Commentary

Need some new swing ideas? Get free weekly swing ideas and market commentary from Jonathan Bernstein here: Swing Trading.

Explore More

Weekly In-Depth Market Analysis and Actionable Trade Ideas

Get institutional-level analysis and trade ideas to take your trading to the next level, sign up for free and become apart of the community.

Read Now

Related Articles

spot_img

WallStreet Waves

Comprehensive stock market news coverage across various asset classes, including stocks, bonds, commodities, cryptocurrencies, and more. We believe in offering a holistic perspective, allowing our readers to stay ahead of the stock market and capitalize on emerging opportunities in tech stocks, small caps, biotechs and more!

most Popular

trending right now

© 2024 All Rights reserved | Powered by WallStreet Waves